SCPHARMACEUTICALS INC. Proceeds from Stock Plans
SCPHARMACEUTICALS INC. reported Proceeds from Stock Plans of $316.00 thousand for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockPlans · last filed 2025-08-07
- SCPHARMACEUTICALS INC. proceeds from stock plans for the quarter ending 2024-12-31 was $171.00K, a 39.36% decline year-over-year.
- SCPHARMACEUTICALS INC. proceeds from stock plans for the quarter ending 2024-09-30 was $0.00.
- SCPHARMACEUTICALS INC. proceeds from stock plans for the quarter ending 2023-12-31 was $282.00K, a 216.85% increase year-over-year.
- SCPHARMACEUTICALS INC. proceeds from stock plans for the quarter ending 2023-09-30 was $0.00.
- SCPHARMACEUTICALS INC. proceeds from stock plans for fiscal 2024 was $454.00K, a 0.87% decline from fiscal 2023.
- SCPHARMACEUTICALS INC. proceeds from stock plans for fiscal 2023 was $458.00K, a 164.74% increase from fiscal 2022.
- SCPHARMACEUTICALS INC. proceeds from stock plans for fiscal 2022 was $173.00K, a 311.90% increase from fiscal 2021.
- SCPHARMACEUTICALS INC. proceeds from stock plans for fiscal 2021 was $42.00K.
| Period end | Proceeds from Stock Plans 3 month | Proceeds from Stock Plans 6 month | Proceeds from Stock Plans 9 month | Proceeds from Stock Plans 12 month |
|---|---|---|---|---|
| 2025-06-30 | $316.00K 10-Q · filed 2025-08-07 | |||
| 2024-12-31 | $171.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | $171.00K derived: sum of 2 quarters · filed 2025-03-19 | $454.00K 10-K · filed 2025-03-19 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $283.00K 10-Q · filed 2024-11-13 | ||
| 2024-06-30 | $283.00K 10-Q · filed 2025-08-07 | |||
| 2023-12-31 | $282.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | $282.00K derived: sum of 2 quarters · filed 2025-03-19 | $458.00K 10-K · filed 2025-03-19 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $176.00K 10-Q · filed 2024-11-13 | ||
| 2023-06-30 | $176.00K 10-Q · filed 2024-08-14 | |||
| 2022-12-31 | $89.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $89.00K derived: sum of 2 quarters · filed 2024-03-13 | $173.00K 10-K · filed 2024-03-13 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $84.00K 10-Q · filed 2023-11-08 | ||
| 2022-06-30 | $84.00K 10-Q · filed 2023-08-10 | |||
| 2021-12-31 | $42.00K 10-K · filed 2023-03-22 |